Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 3.01 Million USD | 32.68% |
| 2019 | 2.27 Million USD | -25.81% |
| 2018 | 3.06 Million USD | -11.04% |
| 2017 | 3.44 Million USD | -25.33% |
| 2016 | 4.61 Million USD | -23.1% |
| 2015 | 6 Million USD | 56906.74% |
| 2014 | 10.53 Thousand USD | -81.32% |
| 2013 | 56.38 Thousand USD | -69.17% |
| 2012 | 182.87 Thousand USD | -69.19% |
| 2011 | 593.48 Thousand USD | -98.19% |
| 2010 | 32.77 Million USD | -22.06% |
| 2009 | 42.05 Million USD | 15.11% |
| 2008 | 36.53 Million USD | -33.0% |
| 2007 | 54.52 Million USD | 189.42% |
| 2006 | 18.84 Million USD | 124.2% |
| 2005 | 8.4 Million USD | 132.85% |
| 2004 | 3.6 Million USD | 0.0% |
| 2002 | 392.92 Thousand USD | -47.79% |
| 2001 | 752.53 Thousand USD | -24.21% |
| 2000 | 992.95 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q4 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2021 Q1 | 2.86 Million USD | -4.95% |
| 2021 FY | - USD | -100.0% |
| 2021 Q3 | 606.42 Thousand USD | -4.09% |
| 2021 Q2 | 632.27 Thousand USD | -77.96% |
| 2020 Q2 | 2.33 Million USD | -5.6% |
| 2020 Q1 | 2.47 Million USD | 8.78% |
| 2020 Q4 | 3.01 Million USD | 21.75% |
| 2020 Q3 | 2.47 Million USD | 6.12% |
| 2020 FY | 3.01 Million USD | 32.68% |
| 2019 Q3 | 2.92 Million USD | -9.19% |
| 2019 FY | 2.27 Million USD | -25.81% |
| 2019 Q4 | 2.27 Million USD | -22.32% |
| 2019 Q2 | 3.22 Million USD | 4.36% |
| 2019 Q1 | 3.08 Million USD | 0.77% |
| 2018 Q4 | 3.06 Million USD | -0.07% |
| 2018 FY | 3.06 Million USD | -11.04% |
| 2018 Q3 | 3.06 Million USD | -4.72% |
| 2018 Q2 | 3.22 Million USD | -3.99% |
| 2018 Q1 | 3.35 Million USD | -2.69% |
| 2017 Q2 | 4.67 Million USD | 0.48% |
| 2017 Q1 | 4.65 Million USD | 0.74% |
| 2017 FY | 3.44 Million USD | -25.33% |
| 2017 Q4 | 3.44 Million USD | -18.34% |
| 2017 Q3 | 4.22 Million USD | -9.66% |
| 2016 Q1 | 5.56 Million USD | 168108.54% |
| 2016 Q4 | 4.61 Million USD | -5.11% |
| 2016 FY | 4.61 Million USD | -23.1% |
| 2016 Q3 | 4.86 Million USD | -11.64% |
| 2016 Q2 | 5.5 Million USD | -1.1% |
| 2015 Q3 | 3578.48 USD | -55.36% |
| 2015 Q2 | 8017.04 USD | -23.86% |
| 2015 Q4 | 3309.50 USD | -7.52% |
| 2015 FY | 6 Million USD | 56906.74% |
| 2015 Q1 | 10.53 Thousand USD | -10.73% |
| 2014 FY | 10.53 Thousand USD | -81.32% |
| 2014 Q3 | 19.4 Thousand USD | -11.47% |
| 2014 Q1 | 56.38 Thousand USD | 34.95% |
| 2014 Q4 | 11.79 Thousand USD | -39.21% |
| 2014 Q2 | 21.91 Thousand USD | -61.13% |
| 2013 Q2 | 101.22 Thousand USD | -44.65% |
| 2013 Q1 | 182.87 Thousand USD | -57.77% |
| 2013 FY | 56.38 Thousand USD | -69.17% |
| 2013 Q4 | 41.78 Thousand USD | -7.52% |
| 2013 Q3 | 45.17 Thousand USD | -55.37% |
| 2012 Q2 | 672.57 Thousand USD | 13.33% |
| 2012 FY | 182.87 Thousand USD | -69.19% |
| 2012 Q3 | 484.51 Thousand USD | -27.96% |
| 2012 Q1 | 593.48 Thousand USD | -96.76% |
| 2012 Q4 | 433.07 Thousand USD | -10.62% |
| 2011 FY | 593.48 Thousand USD | -98.19% |
| 2011 Q4 | 18.3 Million USD | -45.0% |
| 2011 Q3 | 33.28 Million USD | -0.62% |
| 2011 Q1 | 32.77 Million USD | -3.36% |
| 2011 Q2 | 33.48 Million USD | 2.16% |
| 2010 Q4 | 33.92 Million USD | -18.12% |
| 2010 Q1 | 42.05 Million USD | 1.84% |
| 2010 Q2 | 43.22 Million USD | 2.77% |
| 2010 FY | 32.77 Million USD | -22.06% |
| 2010 Q3 | 41.42 Million USD | -4.15% |
| 2009 FY | 42.05 Million USD | 15.11% |
| 2009 Q1 | 36.53 Million USD | -27.59% |
| 2009 Q2 | 35.21 Million USD | -3.61% |
| 2009 Q3 | 38.19 Million USD | 8.45% |
| 2009 Q4 | 41.29 Million USD | 8.12% |
| 2008 Q2 | 51.81 Million USD | -4.98% |
| 2008 Q4 | 50.45 Million USD | -2.73% |
| 2008 FY | 36.53 Million USD | -33.0% |
| 2008 Q1 | 54.52 Million USD | 7.73% |
| 2008 Q3 | 51.86 Million USD | 0.11% |
| 2007 Q1 | 18.84 Million USD | 4.0% |
| 2007 Q2 | 28.99 Million USD | 53.87% |
| 2007 Q3 | 47.61 Million USD | 64.23% |
| 2007 Q4 | 50.61 Million USD | 6.31% |
| 2007 FY | 54.52 Million USD | 189.42% |
| 2006 Q3 | 8.42 Million USD | 3.21% |
| 2006 Q1 | 8.4 Million USD | 104.15% |
| 2006 FY | 18.84 Million USD | 124.2% |
| 2006 Q4 | 18.11 Million USD | 115.05% |
| 2006 Q2 | 8.16 Million USD | -2.88% |
| 2005 Q4 | 4.11 Million USD | 6.2% |
| 2005 Q1 | 3.6 Million USD | 22.07% |
| 2005 Q3 | 3.87 Million USD | 12.57% |
| 2005 FY | 8.4 Million USD | 132.85% |
| 2005 Q2 | 3.44 Million USD | -4.59% |
| 2004 Q2 | 1.22 Million USD | -29.62% |
| 2004 Q1 | 1.74 Million USD | 220.96% |
| 2004 FY | 3.6 Million USD | 0.0% |
| 2004 Q4 | 2.95 Million USD | 105.57% |
| 2004 Q3 | 1.43 Million USD | 17.43% |
| 2003 Q1 | 761.4 Thousand USD | 0.57% |
| 2003 Q4 | 542.14 Thousand USD | 24.38% |
| 2003 Q3 | 435.88 Thousand USD | 10.94% |
| 2003 Q2 | 392.92 Thousand USD | -48.4% |
| 2002 Q3 | 801.9 Thousand USD | 6.56% |
| 2002 Q1 | 968.2 Thousand USD | 5.67% |
| 2002 Q2 | 752.53 Thousand USD | -22.28% |
| 2002 Q4 | 757.09 Thousand USD | -5.59% |
| 2002 FY | 392.92 Thousand USD | -47.79% |
| 2001 Q4 | 916.28 Thousand USD | -11.55% |
| 2001 FY | 752.53 Thousand USD | -24.21% |
| 2001 Q3 | 1.03 Million USD | 0.0% |
| 2000 FY | 992.95 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Avitar, Inc. | 1.74 Million USD | 100.0% |
| BioElectronics Corporation | 144.38 Thousand USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| IR-Med Inc. | 999 Thousand USD | 100.0% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | 100.0% |
| Polarean Imaging plc | 10.86 Million USD | 100.0% |
| AVITA Medical, Inc. | 144.33 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | 100.0% |
| Össur hf. | 1.39 Billion USD | 100.0% |
| Zecotek Photonics Inc. | 2.57 Million USD | 100.0% |
| QHSLab, Inc. | 1.68 Million USD | 100.0% |
| Wellstar International, Inc. | 957.89 Thousand USD | 100.0% |
| Össur hf. | 1.39 Billion USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 100.0% |
| Escalon Medical Corp. | 4.75 Million USD | 100.0% |
| Aurora Spine Corporation | 11.92 Million USD | 100.0% |
| BrainsWay Ltd. | 62.97 Million USD | 100.0% |
| NewCardio, Inc. | 2.85 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 100.0% |
| Vivos Inc. | 1.61 Million USD | 100.0% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 1.63 Million USD | 100.0% |
| REMSleep Holdings, Inc. | 1.2 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | 100.0% |
| Nanomix Corporation | 982.05 Thousand USD | 100.0% |
| Theraclion SA | 18.66 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | 100.0% |
| Positron Corporation | 1.76 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | 100.0% |
| Lombard Medical, Inc. | 67.76 Million USD | 100.0% |
| ALR Technologies Inc. | 193.21 Thousand USD | 100.0% |
| Stratec SE | 529.71 Million USD | 100.0% |
| Vycor Medical, Inc. | 992.29 Thousand USD | 100.0% |
| Heart Tronics, Inc. | 4.04 Million USD | 100.0% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 4.45 USD | 100.0% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 100.0% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | 100.0% |
| United American Healthcare Corporation | 10.37 Million USD | 100.0% |
| ECGI Holdings, Inc. | 5.2 Million USD | 100.0% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 100.0% |
| Urologix, Inc. | 5.66 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 100.0% |
| SS Innovations International, Inc. | 25.47 Million USD | 100.0% |
| Qualis Innovations, Inc. | 2431.00 USD | 100.0% |
| Smith & Nephew plc | 9.97 Billion USD | 100.0% |
| NIOX Group Plc | 116.47 Million USD | 100.0% |
| Fuse Medical, Inc. | 16.25 Million USD | 100.0% |
| Broncus Holding Corporation | 195.75 Million USD | 100.0% |
| Brain Scientific Inc. | 11.74 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 1.04 Million USD | 100.0% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | 100.0% |